The results presented in Figure 7B–E demonstrate that METTL3 overexpression significantly bolstered tumour xenograft resistance to anlotinib‐induced responses, an effect that was negated by co‐transfection with PRKDC shRNA lentivirus. This evidence concerns the gene PRKDC and neoplasm.